Skip to main content

Table 1 Demographic and clinical features (median and interquartile range, mean and standard deviation, or number and percentage)

From: Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial

Characteristics

Group I: Butorphanol (n = 95)

Group II: Normal Saline (n-99)

Sig

Age(years)

49(23–67)

49(26–65)

0.727

Gender(male/female)

43/53

50/49

0.465

Height(cm)

167(9)

166(8)

0.898

Weight(kg)

68(12)

66(12)

0.248

BMI(kg/m2)

24.5(3.3)

24.8(3.0)

0.109

Smoking history(%)

26(27.4)

34(34.3)

0.293

Drinking history(%)

38(40.0)

43(43.4)

0.628

Hypertension(%)

31(32.6)

20(20.2)

0.049

Diabetes mellitus(%)

9(9.5)

7(7.1)

0.543

Hyperlipemia(%)

20(21.1)

17(17.2)

0.492

Heart disorders(%)

3(3.2)

5(5.1)

0.508

Coronary heart disease

1(1.1)

2(2.0)

 

Heart valve disease

1(1.0)

0(0)

 

Arrhythmia

0(0)

2(2.0)

 

ASA physical status

 I

67

66

0.563

 II

28

33

 

Type of operations

 Total

95

99

0.886

 Colonoscopy

47

48

 

 Gastro-colonoscopy

50

49

 
  1. BMI body mass index, ASA American Society of Anesthesiologists